Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Karen Pry"'
1
Data from KRAS Mutation Status Is Associated with Enhanced Dependency on Folate Metabolism Pathways in Non–Small Cell Lung Cancer Cells
Autor: Sarah S. Bacus, David Sidransky, Keren Paz, Karen Pry, Patricia B. Trusk, Diarmuid M. Moran
KRAS gene mutation is linked to poor prognosis and resistance to therapeutics in non–small cell lung cancer (NSCLC). In this study, we have explored the possibility of exploiting inherent differences in KRAS-mutant cell metabolism for treatment. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6224b879257a08264438939e97acf6d
https://doi.org/10.1158/1535-7163.c.6536542.v1
Zobrazit plný text záznamu
2
Supplementary Table 2 from KRAS Mutation Status Is Associated with Enhanced Dependency on Folate Metabolism Pathways in Non–Small Cell Lung Cancer Cells
Autor: Sarah S. Bacus, David Sidransky, Keren Paz, Karen Pry, Patricia B. Trusk, Diarmuid M. Moran
PDF - 68K, Normalized basal gene expression microarray data for non-squamous NSCLC NCI60 cell lines were grouped according to KRAS mutation status. Genes showing significant differences in expression between KRAS mutant and KRAS wildtype cells were a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52000bf10937f7e1bb188611ab2d0f9
https://doi.org/10.1158/1535-7163.22500685
Zobrazit plný text záznamu
4
Supplementary Table 1 from KRAS Mutation Status Is Associated with Enhanced Dependency on Folate Metabolism Pathways in Non–Small Cell Lung Cancer Cells
Autor: Sarah S. Bacus, David Sidransky, Keren Paz, Karen Pry, Patricia B. Trusk, Diarmuid M. Moran
PDF - 75K, Normalized basal gene expression microarray data for non-squamous NSCLC NCI60 cell lines were grouped according to KRAS mutation status. Genes showing significant differences in expression between KRAS mutant and KRAS wildtype cells were a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32970d1854abf60ef96c4f6544ff989a
https://doi.org/10.1158/1535-7163.22500688.v1
Zobrazit plný text záznamu
8
Supplementary Table 3 from KRAS Mutation Status Is Associated with Enhanced Dependency on Folate Metabolism Pathways in Non–Small Cell Lung Cancer Cells
Autor: Sarah S. Bacus, David Sidransky, Keren Paz, Karen Pry, Patricia B. Trusk, Diarmuid M. Moran
PDF - 69K, Normalized basal gene expression microarray data for non-squamous NSCLC NCI60 cell lines were grouped according to KRAS mutation status. Genes showing significant differences in expression between KRAS mutant and KRAS wildtype cells were a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103fa5a94022bf8a7d1b9ac3883e907d
https://doi.org/10.1158/1535-7163.22500682.v1
Zobrazit plný text záznamu
10
Immune profiling reveals the diverse nature of the immune response in NSCLC and reveals signaling pathways that may influence the anti-tumor immune response
Autor: Christopher A. Hamm, Sarah S. Bacus, Karen Pry, Jim Lu
Publikováno v: Experimental and Molecular Pathology. 109:1-15
Recent FDA approvals of immunotherapy for NSCLC provide patients new treatment options, and these approvals also highlight the importance of the immune response in cancer treatment. While immunotherapy provides patients a new treatment option, the th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9d3cd18de1aa44d68d249e2035490c
https://doi.org/10.1016/j.yexmp.2019.04.004
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje